Introduction
Throughout the history of the world, the ones who had confronted the bitterest face of poverty and war had always been the women. As known poverty and war affects human health either directly or indirectly, the effects of this condition on health and status of women in the society should not be ignored. This study intends to cast light on the effects of war and poverty on the reproductive health of women. For this purpose, the face of war affecting the women, the problem of immigration, inequalities in distribution of income based on gender and the effects of all these on the reproductive health of women will be addressed.
War and Women's Health
Famine, synonymous with war and poverty, is clearer for women; war means deep disadvantages such as full destruction, loss of future and uncertainty for women. Wars are conflicts that destroy families, societies and cultures that negatively affect the health of community and cause violation of human rights. According to the data of World Health Organization (WHO) and World Bank, in 2002 wars had been among the first ten reasons which killed the most and caused disabilities. Civil losses are at the rate of 90% within all losses (1) . War has many negative effects on human health. One of these is its effect of shortening the average human life. According to the data of WHO, the average human life is 68.1 years for males and 72.7 years for females. It is being thought that severe military conflicts in Africa shorten the expected lifetime for more than 2 years. In general, WHO had calculated that 269 thousand people had died in 1999 due to the effect of wars and that loss of 8.44 million healthy years of life had occurred (2, 3) . Wars negatively affect the provision of health services. Health institutions such as hospitals, laboratories and health centers are direct targets of war. Moreover, the wars cause the migration of qualified health employees, and thus the health services hitches. Assessments made indicate that the effect of destruction in the infrastructure of health continues for 5-10 years even after the finalization of conflicts (3) . Due to resource requirements in the restructuring investments after war, the share allocated to health has decreased (1).
Mortalities and Morbidities
The ones who are most affected from wars are women and children. While deaths depending on direct violence affect the male population, the indirect deaths kill children, women and elders more. In Iraq between 1990-1994, infant deaths had shown this reality in its more bare form with an increase of 600% (4). The war taking five years increases the child deaths under age of 5 by 13%. Also 47% of all the refugees in the world and 50% of asylum seekers and displaced people are women and girls and 44% refugees and asylum seekers are children under the age of 18 (5) . As the result of wars and armed conflicts, women are
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War and poverty are 'extraordinary conditions created by human intervention' and 'preventable public health problems. ' War and poverty have many negative effects on human health, especially women's health. Health problems arising due to war and poverty are being observed as sexual abuse and rape, all kinds of violence and subsequent gynecologic and obstetrics problems with physiological and psychological courses, and pregnancies as the result of undesired but forced or obliged marriages and even rapes. Certainly, unjust treatment such as being unable to gain footing on the land it is lived (asylum seeker, refugee, etc.) and being deprived of social security, citizenship rights and human rights brings about the deprivation of access to health services and of provision of service intended for gynecology and obstetrics. The purpose of this article is to address effects of war and poverty on the health of reproduction of women and to offer scientific contribution and solutions. the third day of the menstrual cycle, endocrinological disorders, and presence of congenital uterine anomalies. The sample consisted of 160 women who referred to Moheb Yas hospital. A long ovarian stimulation protocol using a GnRH agonist was applied. 0.5 mg buserelin acetate (Superfact, Sanofi, Canada) was administered from day 21 of the cycle. On the first day of menstruation, GnRH dose was reduced by half and FSH ampule, Gonal F (Serono), was added. All cases underwent trans-vaginal ultrasound examination until 17-18 mm follicles were observed, and then 10000 IU hCG (Pregnyl, Organon) was injected to stimulate the ovary. Then, the oocyte pick up was performed using a soft catheter under ultrasound guidance and spinal anesthesia. Sperm and oocytes were put together in the lab after oocyte retrieval. In women with a poor history of IVF, the sperm was injected into an oocyte. In the following morning, oocytes were checked for the evidence of fertilization. The embryos were cultured in the IVF lab for 3 days.
Embryo transfer (1-5 embryos) was performed in women with transferable embryos three days after oocyte picking up using a Cook catheter. The number of embryos transferred to the uterus depends on the women's age and the quality of embryos. No more than five embryos were transferred. If more than five good embryos were obtained, they were frozen for further use.
After retrieving oocytes, 100 mg of progesterone per day were injected for three days, then the luteal phase was supported by Cyclogest suppository (Alpharma, Barnstaple, UK), 400 mg for 12 weeks. Pregnancy was assessed by measurement of serum hCG 14-15 days after ET and was then confirmed by ultrasound which visualized at least one gestational sac after two further weeks.
Measurements AMH was measured on day 3 of the menstrual cycle in the endocrinology lab of the hospital. Progesterone and estradiol were measured on the morning of hCG administration. Endometrial thickness was measured on the day of oocyte retrieval by transvaginal ultrasound. Oocytes were retrieved by transvaginal ultrasoundguided aspiration approximately 36 hours after hCG injection. After fertilization of the oocytes with sperms, two physicians categorized blastocysts as good, fair, or poor grade blastocysts, according to the simplified SART embryo scoring system (18) . Statistical Analysis SPSS version 22.0 was used for data analysis. Normality of the numeric variables was assessed using ShapiroWilk test. Sample characteristics were determined by means and frequencies. Student t test, ANOVA, and Mann-Whitney U test were used for comparison of the continuous variables. Chi-square and Fisher exact tests were used for comparison of the categorical variables. Logistic regression analysis was applied for odds ratio (OR) calculation. A P value less than 0.05 was considered statistically significant.
Results
One hundred and sixty women who were referred to Moheb Yas hospital were enrolled in this study. Table 1 shows demographic characteristics of the pregnant and non-pregnant participants. The grade of 91.8% of embryos was good. Progesterone levels on the day of hCG injection in 76% of cases were lower than 1 ng/mL. Estradiol levels on the day of hCG injection were higher than 1000 pg/ mL in 77% of the cases. AMH ≤0.6 was observed in 50.6% of the cycles. Table 2 shows laboratory characteristics of the pregnant and non-pregnant participants. There was no relationship between IVF success and the levels of progesterone and estradiol, maternal age and body mass index (BMI), and the number of embryos transferred. Maternal age was correlated with the oocyte and embryo number (r = -0.16, P = 0.05).
A significant relationship was found between IVF success and AMH levels, the number of FSH injections, endometrial thickness, embryos grading, and number of the embryos produced. Logistic regression analysis with pregnancy as the dependent variable showed that among AMH, endometrial thickness, number of FSH ampule, embryo grade, and the number of embryo produced, only AMH is an independent predictor of IVF success (OR = (Table 3) . As expected, the number of FSH ampule was higher in women with AMH ≤0.6 compared to those with AMH were >0.6 (P = 0.002). In addition, endometrial thickness was higher in women with AMH >0.6 compared to those with AMH ≤0.6 were (P = 0.001). Although we found no relationship between women's age and IVF success, further analysis showed a significant relationship between AMH level and IVF success in women ≤35. (Table 4 ).
Discussion
We evaluated the role of different factors in the success of IVF/ET in infertility center of Moheb Yas hospital, Tehran, Iran. The results of our study indicate that AMH is a predictor of IVF success. Further analysis showed a significant relationship between AMH level and IVF success in women ≤35, indicating that IVF success was significantly higher in younger women with higher level of AMH than those with a low level of AMH. The overall success rate of IVF/ET in this study was 20.6%. AMH is commonly used as a biomarker for evaluating the ovarian reserve. AMH serum level expresses the number of growing follicles and predicts ovarian response to stimulation (19) . In a study by Cohen et al, it was shown that women with a low level of the ovarian reserve had low live birth rates after the first IVF (20) . In previous studies, clinical pregnancy rate (15), live birth rates (21) , the number of retrieved oocytes, and IVF fertilization rate (22) were influenced by AMH. In a study by Silva et al, AMH levels ≤0.70 accounted for 92% of the IVF failures (23).
Although we found a relationship between AMH and IVF success, we did not find any relationship between women's age and IVF success. Our result is congruent with the result of a study conducted by Verma in which no significant relationship was observed between AMH levels with maternal age (24) . In contrast, the results of 2 studies showed that AMH was inversely correlated with women's age which means that women's higher age reduced ovarian reserve (21, 25) . In a recent study, AMH could predict ovarian reserve in different age groups; however, female age was found to be a better predictor of IVF outcome than AMH (17) .
We found a significant relationship between AMH level and IVF success in women ≤35 while Goswami and Nikolaou reported that older women with higher AMH level had higher live birth rate than those with low AMH level (26) .
We also did not find any relationship between BMI and IVF success which is in harmony with the results of a study conducted by MacKenna et al in Latin America. In the study by MacKenna which was conducted on a sample of women with a high prevalence of obesity, BMI did not influence the outcome of ART (27) .
In our study, 29% of embryos had good quality and we found a relationship between the quality of blastocyst and IVF success. In a study on 350 intracytoplasmic sperm injection (ICSI) cycles, transferring one grade 1 or grade 2 blastocyst significantly increased implantation and pregnancy rates (28) . The results of another study on 107 a AMH ≤0.6 vs. >0.6; *** P < 0.001. patients undergoing IVF/ET showed that transferring two top-grade blastocysts increased implantation, pregnancy, and twinning rates to 70%, 87%, and 61%, respectively. In contrast, by transferring low-grade blastocysts, the aforementioned rates were 28%, 44%, and 29%, respectively (29) . We found no relationship between progesterone level and clinical or chemical pregnancies in women undergoing IVF. Our result was in agreement with the results of the previous study showing no significant relationship between the level of progesterone in the late follicular phase and the pregnancy rate (30) . However, it is suggested that elevated progesterone level will adversely affect the endometrial environment and decrease the pregnancy rate (31) . In a study, Labarta et al showed that the elevation of progesterone levels on the day of hCG injection may intervene in normal endometrial function through changes in the endometrial gene expression profile (32) . The results of a systematic review conducted by Venetis et al on more than 4000 cycles showed that progesterone level on the day of hCG administration is associated with lower pregnancy rate (33) .
We found no relationship between estradiol level on the day of hCG injection and IVF success. The results of a study by Foroozanfard et al indicates a positive correlation between estradiol level and IVF pregnancy rate (16) . In contrast, Kondapalli et al showed that a decrease of <10% in estradiol levels after hCG injection reduced pregnancy rate (34) . Our result was in line with previous studies which found that the increased estradiol level on the day of hCG injection did not improve IVF pregnancy outcome (35, 36) .
In our study, endometrial thickness on the day of oocyte retrieval was higher in pregnant women compared to non-pregnant women. Our results were in harmony with the findings of the previous studies which found a positive correlation between endometrial thickness and pregnancy rate (37, 38) . Further research is needed to determine an appropriate cut-off point of endometrial thickness for good IVF outcome.
We found that women who became pregnant had produced a higher number of embryos in IVF cycles than non-pregnant did. A study conducted by Kovacs et al also showed more follicles, oocytes and therefore more embryos among pregnant women compared to nonpregnant women in IVF cycles (37) .
In this study, the success rate of IVF was 20.6% which is lower compared to live birth rates of 27.1% (39), 36% (22) , and 28.2% reported in previous studies (38) . Considering the fact that IVF success is usually higher than the live birth rate, measures should be performed to improve the success rate of IVF in this center.
In this study, we only assessed the pregnancy rate after IVF. Since the pregnancy rate may not be the same as the live birth rate, further follow-up studies are needed to evaluate the ability of AMH to predict live birth. We also did not follow pregnancies to categorize them as normal or pathological. We recommend that in future studies longterm follow-up of IVF cycles be performed to determine the factors predicting pregnancy complications.
Conclusions
The overall success rate of IVF/ET was 20.6%. AMH was an independent predictor of IVF success after adjustment for the number of embryos produced. Due to the small sample size in studies in Iran, we recommend that a meta-analysis on the factors involving in IVF success be conducted.
Limitations
A limitation of the study is its small sample size. We suggest that further studies with a larger sample size from multiple centers be conducted.
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